Bioactive sustained-release composition
A slow-release composition and bioactive technology, applied in cosmetics, preparations for skin care, medical preparations containing active ingredients, etc., can solve the problems of inability to fully exert the efficacy of astaxanthin, decomposing inactivation, skin irritation, etc., Achieve the effect of promoting sustained release, improving whitening, and plumping cell shape
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0047] The preparation method of the bioactive slow-release composition of the present invention comprises the following steps:
[0048] The raw materials of the bioactive sustained-release composition of the present invention are mixed and stirred evenly to obtain the bioactive sustained-release composition.
[0049] The second aspect of the present invention provides an application of the bioactive sustained-release composition, which can be applied in skin care products.
[0050] In one embodiment, the skin care products of the present invention include lotion, lotion, face cream, eye cream, mask, BB cream, essence, sunscreen, sunscreen lotion, acne lotion, acne lotion, essential oil, moisturizing water, toner , Astringent water, softening water.
[0051] The emulsion and face cream of the present invention are liquid cream cosmetics. The facial mask of the present invention is a carrier of beauty care products, including but not limited to mud cream type, tear type, jell...
Embodiment 1
[0057] Embodiment 1 of the present invention provides a bioactive sustained-release composition, the raw materials of the bioactive sustained-release composition include 5 parts of astaxanthin, 45 parts of dipalmitoylphosphatidylcholine, 8 parts of Cholesterol, 1 part stearylamine, 15 parts deionized water, 5 parts ethanol.
[0058] The astaxanthin CAS number is 472-61-7; the dipalmitoylphosphatidylcholine CAS number is 2797-68-4; the cholesterol CAS number is 57-88-5; the stearylamine CAS No. 124-30-1.
[0059] This example discloses the preparation method of the biologically active sustained-release composition, comprising the following steps:
[0060] The raw materials of the bioactive sustained-release composition of the present invention are mixed and stirred evenly to obtain the bioactive sustained-release composition.
[0061] This example provides a kind of essence, comprises described bioactive sustained-release composition, and preparation method comprises the follow...
Embodiment 2
[0064] Embodiment 2 of the present invention provides a bioactive sustained-release composition. The raw materials of the bioactive sustained-release composition include 15 parts of astaxanthin, 55 parts of dipalmitoylphosphatidylcholine, 15 parts of Cholesterol, 3 parts stearylamine, 20 parts deionized water, 15 parts ethanol.
[0065] The astaxanthin CAS number is 472-61-7; the dipalmitoylphosphatidylcholine CAS number is 2797-68-4; the cholesterol CAS number is 57-88-5; the stearylamine CAS No. 124-30-1.
[0066] This example discloses the preparation method of the bioactive sustained-release composition, and its specific implementation method is the same as that of Example 1.
[0067] This example discloses an essence, including the biologically active sustained-release composition, the specific preparation method of which is the same as that of Example 1.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com